Terminated × Neoplasms × Other hematologic neoplasm × Clear all YASU Research Registry: For Young Adults With Cancer
Terminated
192 enrolled
VIALE-T
Phase 3 Terminated
465 enrolled
ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals
Phase NA Terminated
2,117 enrolled 6 charts
EPC-EMA1
Phase NA Terminated
15 enrolled
Study of a Triple Combination Therapy, DTRM-555, in Patients With R/R CLL or R/R Non-Hodgkin's Lymphomas
Phase 2 Terminated
55 enrolled
CYNK001AML01
Phase 1 Terminated
27 enrolled
A Study of TAK-981 in People With Advanced Solid Tumors or Cancers in the Immune System
Phase 1/2 Terminated
109 enrolled 54 charts
A Clinical Trial to Learn About the Study Medicine Called Maplirpacept (PF-07901801), Alone and When Used in Combination With Other Medicines to Treat Participants With Advanced Hematological Malignancies, Including Lymphoma, Leukemia and Multiple Myeloma
Phase 1 Terminated
189 enrolled
Uproleselan With Pre-Transplant Conditioning in Hematopoietic Stem Cell Transplantation for AML
Phase 1 Terminated
1 enrolled
A Phase 1 Study of AMG 330 in Subjects With Myeloid Malignancies
Phase 1 Terminated
95 enrolled 47 charts
LAUREL
Phase 1 Terminated
2 enrolled
QUILT-3.002: N-803 in Patients With Relapse/Refractory iNHL in Conjunction With Rituximab
Phase 1/2 Terminated
43 enrolled 15 charts
Study to Evaluate Adverse Events and Movement of Lemzoparlimab in Body When Used Intravenously (IV) With Azacitidine Subcutaneously or IV and Venetoclax Orally in Participants With Acute Myeloid Leukemia and With Azacitidine With or Without Venetoclax in Participants With Myelodysplastic Syndrome
Phase 1 Terminated
40 enrolled
Screening Protocol for Preliminary Eligibility Determination for Adoptive Cell Therapy Trials
Phase 2 Terminated
16 enrolled 5 charts
ENAVEN-AML
Phase 1/2 Terminated
27 enrolled
Acute Lymphoblastic Leukemia Therapies Informed by Genomic Analyses
Phase NA Terminated
21 enrolled
Study Investigating NTLA-5001 in Subjects With Acute Myeloid Leukemia
Phase 1/2 Terminated
6 enrolled 11 charts
Phase 1/2 Study of TP-0903 (an Inhibitor of AXL Kinase) in Patients With Previously Treated CLL
Phase 1/2 Terminated
3 enrolled 7 charts
A Phase 1b/2 Study of Alvocidib Plus Decitabine or Azacitidine in Patients With MDS
Phase 1/2 Terminated
20 enrolled 13 charts
NiiCproject
Terminated
58 enrolled
A Phase 1/2 Study To Evaluate ASN002 In Relapsed/Refractory Lymphoma And Advanced Solid Tumors
Phase 1/2 Terminated
51 enrolled 18 charts
Hypertension Management in Cancer Patients
Phase NA Terminated
4 enrolled
PIVOT IO 020
Phase 1/2 Terminated
15 enrolled 14 charts
Study to Investigate the Safety and Clinical Activity of GSK3326595 and Other Agents to Treat Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)
Phase 1/2 Terminated
30 enrolled 29 charts
Study to Evaluate Adverse Events, Change in Disease Activity, Movement of Oral ABBV-623 and ABBV-992 Tablets in the Body of Adult Participants With B-cell Cancers
Phase 1 Terminated
5 enrolled
A Study of Venetoclax and Dinaciclib (MK7965) in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Phase 1 Terminated
48 enrolled
FIRST
Terminated
5 enrolled
A Study to Determine Safety, Tolerability, Pharmacokinetics, and Recommended Phase 2 Dose (RP2D) of Intravenous ABBV-184 in Adult Participants With Previously Treated Cancers
Phase 1 Terminated
14 enrolled
MT-3724NHL001
Phase 1/2 Terminated
38 enrolled 20 charts
Study of PTC299 (Emvododstat) in Relapsed/Refractory Acute Leukemias
Phase 1 Terminated
33 enrolled
Medical Treatment Decision Making Using Adaptive Conjoint Analysis
Terminated
25 enrolled
A Study of Venetoclax and AMG 176 in Patients With Relapsed/Refractory Hematologic Malignancies
Phase 1 Terminated
9 enrolled
OPTIC-2L
Phase 3 Terminated
44 enrolled 22 charts
Impact of Phone Call About Financial Reimbursement Program on Access to Cancer Clinical Trials
Phase NA Terminated
252 enrolled
Safety, PK, PD, and Antitumor Activity of Vecabrutinib (SNS-062) in B Lymphoid Cancers
Phase 1/2 Terminated
39 enrolled
Alemtuzumab and Clofarabine for Relapsed or Refractory Acute Lymphoblastic Leukemia
Phase 1/2 Terminated
6 enrolled 6 charts
Dimethylfumarate (DMF) in Relapsed/Refractory CLL/SLL
Phase 1 Terminated
2 enrolled 5 charts
Study of Immune Response Modifier in the Treatment of Hematologic Malignancies
Phase 2 Terminated
6 enrolled 8 charts
A Phase I Dose Escalation Study of GSK2879552 in Subjects With Acute Myeloid Leukemia (AML)
Phase 1 Terminated
41 enrolled 34 charts
COMPLEMENT 1
Phase 3 Terminated
447 enrolled 32 charts
Idelalisib in Combination With Rituximab for Previously Untreated Follicular Lymphoma and Small Lymphocytic Lymphoma
Phase 2 Terminated
10 enrolled 10 charts
N1
Terminated
23 enrolled
Clinical Study of Plitidepsin (Aplidin®) in Combination With Cytarabine in Patients With Relapsed/Refractory Leukemia
Phase 1/2 Terminated
3 enrolled 6 charts
Genetic Susceptibility and Risk of Second Cancers in Patients Who Have Undergone Stem Cell Transplant for Cancer
Terminated
1,000 enrolled
Micafungin
Phase 1 Terminated
9 enrolled
Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant
Phase 2 Terminated
12 enrolled 12 charts
Low-dose Oral Clofarabine for the Treatment of IPSS INT-1, INT-2 or HIGH Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia
Phase 1/2 Terminated
11 enrolled 11 charts
REGKINE
Phase NA Terminated
26 enrolled 7 charts
Efficacy of a Patient Education Video
Phase NA Terminated
9 enrolled
Influenza Vaccine in Preventing Flu in Patients Who Have Undergone Stem Cell Transplant and in Healthy Volunteers
Phase NA Terminated
9 enrolled